Literature DB >> 10555981

Functional characterization of the CFTR R domain using CFTR/MDR1 hybrid and deletion constructs.

A Vankeerberghen1, W Lin, M Jaspers, H Cuppens, B Nilius, J J Cassiman.   

Abstract

To improve our insight into the structure and function of the CFTR R domain, deletion and hybrid constructs in which different parts of the R domain were deleted or replaced by the MDR1 linker domain, and vice versa, were made. Replacement of the linker domain by the R domain did not result in a decrease and replacement of the CFTR R domain by the linker domain did not result in an increase of maturation efficiency, when compared to the respective wild-type proteins. This indicates that the R domain is not responsible for the high degree of degradation observed for CFTR translation products in the ER, but rather the overall structure or sequences located outside the R domain. Replacing the C-terminal part of the R domain (amino acids 780-830) by the MDR1 linker domain resulted in the appearance of PKA-dependent whole cell chloride currents which were not significantly different from wild-type CFTR currents. This might indicate that the PKA sites present in the linker domain are functional and that not the exact sequence of the C-terminal part of the R domain is important, but rather the presence of PKA sites and the length. Moreover, when this hybrid construct was PKC-stimulated, chloride currents were activated. Although these PKC-induced currents were lower than the PKA-induced ones, this again indicates that the linker domain is functional in this hybrid construct. Taken together, these results suggest that the MDR1 linker domain can substitute for part of the regulatory domain of the CFTR protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10555981     DOI: 10.1021/bi991520d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Size comparisons among integral membrane transport protein homologues in bacteria, Archaea, and Eucarya.

Authors:  Y J Chung; C Krueger; D Metzgar; M H Saier
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

2.  The inhibition mechanism of non-phosphorylated Ser768 in the regulatory domain of cystic fibrosis transmembrane conductance regulator.

Authors:  Guangyu Wang
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

3.  CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo.

Authors:  Lynda S Ostedgaard; Joseph Zabner; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Arlene A Stecenko; Christoph Randak; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

4.  State-dependent regulation of cystic fibrosis transmembrane conductance regulator (CFTR) gating by a high affinity Fe3+ bridge between the regulatory domain and cytoplasmic loop 3.

Authors:  Guangyu Wang
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

5.  Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR.

Authors:  Tamás Hegedus; Adrian W R Serohijos; Nikolay V Dokholyan; Lihua He; John R Riordan
Journal:  J Mol Biol       Date:  2008-03-26       Impact factor: 5.469

6.  PKC-mediated stimulation of amphibian CFTR depends on a single phosphorylation consensus site. insertion of this site confers PKC sensitivity to human CFTR.

Authors:  B Button; L Reuss; G A Altenberg
Journal:  J Gen Physiol       Date:  2001-05       Impact factor: 4.086

7.  Role for SUR2A ED domain in allosteric coupling within the K(ATP) channel complex.

Authors:  Amy B Karger; Sungjo Park; Santiago Reyes; Martin Bienengraeber; Roy B Dyer; Andre Terzic; Alexey E Alekseev
Journal:  J Gen Physiol       Date:  2008-03       Impact factor: 4.086

8.  The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator.

Authors:  Eva Y Chen; David M Clarke
Journal:  BMC Biochem       Date:  2002-10-02       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.